SCHEMBL29587808

SCHEMBL29587808

COc1ccc(C(C)(C)C)cc1S(=O)(=O)NC(=O)c1cc2c(F)cc(C3CC3)cc2o1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.37
TRIM24 O15164 5/20 0.37
ALPL P05186 1/20 0.36
WDR5 P61964 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
LMNA P02545 2/20 0.35
STS P08842 1/20 0.35
MCHR1 Q99705 3/20 0.35
KCNH2 Q12809 2/20 0.35
BRPF1 P55201 1/20 0.34
GAA P10253 1/20 0.33
ALOX12 P18054 1/20 0.33
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24314184 1.00 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2TRIM24ALPLWDR5
SCHEMBL24313699 0.91 SCN9A (0.35) ALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL29587622 0.91 SCN9A (0.35) ALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL24313774 0.91 TRIM24 (0.41) ALDH1A1SMN1; SMN2TRIM24MEN1KMT2A
SCHEMBL29588213 0.91 ALDH1A1 (0.34) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL24313805 0.91 ALDH1A1 (0.34) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL29587885 0.90 TRPV1 (0.35) ALDH1A1LMNA
SCHEMBL24313960 0.90 TRPV1 (0.35) ALDH1A1LMNA
SCHEMBL24314323 0.89 SCN9A (0.38)
SCHEMBL29588250 0.89 SCN9A (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229045-B1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER BROAD INST INC (US) 2025-11-12 EP claimed
EP-4229045-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute Inc. (US) 2023-08-23 EP claimed
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO claimed
EP-4229045-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute Inc. (US) 2023-08-23 EP disclosed
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed